E2V.L Regulatory News (E2V)

8 Sep 2005 11:30

e2v technologies PLC08 September 2005 8 September 2005 e2v technologies plc AGM STATEMENT At the conclusion of the AGM, which will be held at 11.30am today, the Chairman,George Kennedy, will make the following statement: "Since the year end the Group has announced three significant contract wins andcompleted its first acquisition since flotation. The contract wins for the GAIAspace imaging programme, the Typhoon aircraft and x-ray dental sensors underpinthe organic growth expectations of the group. The acquisition of GreshamScientific Instruments Limited, completed in July, gives us the opportunity todeliver additional growth from our Sensors product group. We continue to experience strong demand for our Sensor product range and inparticular our dental x-ray sensors. Within our Electronic Tube products we arealso seeing increased demand from the Commercial and Industrial sector for highpower UHF TV broadcast in the USA, and marine radar applications, as well asincreased sales in the Medical and Science sector for radiotherapy. Theseincreases in demand compensate for modest growth in Aerospace and Defence. Our programmes to deliver productivity improvements and re-skill the business inspecific areas continue and in the first half of this financial year thebusiness incurred £0.5m of severance costs. Strong demand for our products and the impact of the Gresham acquisitionconfirms our view that the Group is well placed to deliver continued growth." Enquiries: e2v technologies plc +44 (0)1245 453424Keith Attwood, CEOMike Hannant, Finance Director Gavin Anderson & Company +44 (0)20 7554 1400Charlotte Stone / Fergus Wylie NOTES FOR EDITORS e2v technologies delivers the radio frequency and sensing technology thatenables some of the world's most innovative medical and science, aerospace anddefence, and industrial and commercial systems. For the year ended 31 March2005, e2v achieved sales of £100.5m. The Group is listed on the London StockExchange (E2V.L) and is a constituent of the FTSE techMARK AllShare Index. e2v is a leading developer and manufacturer of high-technology electroniccomponents and subsystems, which it supplies into niche markets as follows: - Medical & Science: including dental x-ray, radiotherapy cancer treatment and other life science applications; - Aerospace & Defence: including military surveillance, space based imaging and astronomy, radar and electronic warfare and countermeasures; - Commercial & Industrial: including marine radars, automotive radars and alarms, cameras used by firefighters, TV broadcast and satellite communications and food/industrial processing. It has offices in UK, USA, Germany, France, Canada and China supported by aglobal network of agents and distributors covering other key territories. Further information on e2v technologies plc is available from its website,www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange